Contact
Please use this form to send email to PR contact of this press release:
Active Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical Trial of Naptumomab
TO:
Please use this form to send email to PR contact of this press release:
Active Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical Trial of Naptumomab
TO: